Want to join the conversation?
$CYNO said it got approval from Korean Ministry of Food and Drug Safety (MFDS) to market SculpSure for non-invasive lipolysis of abdomen and flanks. The product will be marketed through its direct sales force in Korea beginning in 3Q16. SculpSure is effective non-invasive treatment that eliminates up to 24% of treated fat in 25-minute procedure.
$RAI has received a $47 billion take over offer from British tobacco giant British American Tobacco! This is huge!
No better outlook on $MSFT. Even if the results beat a bit, the stock may move 4 to 6% higher, but won't go above $60.